Cargando…

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

BACKGROUND: Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dell’Osso, Bernardo, Arici, Chiara, Dobrea, Cristina, Camuri, Giulia, Benatti, Beatrice, Altamura, A Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573802/ https://www.ncbi.nlm.nih.gov/pubmed/23429980 http://dx.doi.org/10.2147/NDT.S39322

Ejemplares similares

Duloxetine in Affective Disorders: a Naturalistic Study on Psychiatric and Medical Comorbidity, Use in Association and Tolerability Across Different Age Groups
por: Dell’Osso, Bernardo, et al.
Publicado: (2012)

Cognitive Performance in Euthymic Patients with Bipolar Disorder vs Healthy Controls: A Neuropsychological Investigation
por: Palazzo, M. Carlotta, et al.
Publicado: (2017)

Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression
por: Dell’Osso, Bernardo, et al.
Publicado: (2011)

Partial Response to Antidepressant Treatment: The Role of Nutraceutical Compounds
por: Girone, Nicolaja, et al.
Publicado: (2023)

Transcranial Brain Stimulation Techniques For Major Depression: Should We Extend TMS Lessons to tDCS?
por: Dell’Osso, Bernardo, et al.
Publicado: (2014)

Has Bipolar Disorder become a predominantly female gender related condition? Analysis of recently published large sample studies
por: Dell’Osso, Bernardo, et al.
Publicado: (2021)

Epidemiologic and clinical updates on impulse control disorders: a critical review
por: Dell’Osso, Bernardo, et al.
Publicado: (2006)

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
por: Dell’Osso, Bernardo, et al.
Publicado: (2018)

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine
por: Buoli, Massimiliano, et al.
Publicado: (2013)

Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
por: Marcatili, Matteo, et al.
Publicado: (2020)

Gender impact on the outcome of rehabilitation programs in psychiatry: Brief report from a metropolitan residential rehabilitative service
por: Cafaro, Rita, et al.
Publicado: (2023)

First vs second wave of COVID-19 pandemic in patients with obsessive compulsive disorder: A multicentre report from tertiary clinics in Northern Italy
por: Benatti, Beatrice, et al.
Publicado: (2022)

The Role of Lifestyle on Adherence to Treatment in a Sample of Patients with Unipolar and Bipolar Depression
por: Benatti, Beatrice, et al.
Publicado: (2023)

A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression
por: Larini, L., et al.
Publicado: (2023)

Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
por: Hart, Xenia M., et al.
Publicado: (2023)

What Happened to Patients With Obsessive Compulsive Disorder During the COVID-19 Pandemic? A Multicentre Report From Tertiary Clinics in Northern Italy
por: Benatti, Beatrice, et al.
Publicado: (2020)

Intensive Neurofeedback Protocol: An Alpha Training to Improve Sleep Quality and Stress Modulation in Health Care Professionals During the Covid-19 Pandemic. A Pilot Study
por: Benatti, Beatrice, et al.
Publicado: (2023)

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
por: Battini, Vera, et al.
Publicado: (2023)

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset
por: Dell’Osso, Bernardo, et al.
Publicado: (2009)

Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors
por: Marazziti, Donatella, et al.
Publicado: (2006)

Effect of Escitalopram on White Blood Cells in Patients With Major Depression
por: Canan, Fatih, et al.
Publicado: (2009)

Colorimetric Method for the Estimation of Escitalopram Oxalate in Tablet Dosage Form
por: Vetrichelvan, T., et al.
Publicado: (2010)

Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
por: Vismara, Matteo, et al.
Publicado: (2022)

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder
por: Hart, X. M., et al.
Publicado: (2022)

Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease
por: D'Addario, Claudio, et al.
Publicado: (2012)

Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patient
por: Miyazaki, Kensuke
Publicado: (2022)

Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial
por: Choi, Kwan-Woo, et al.
Publicado: (2012)

Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review
por: Dell'Osso, Bernardo, et al.
Publicado: (2005)

Changes in peripheral benzodiazepine receptors in patients with bipolar disorder
por: Marazziti, Donatella, et al.
Publicado: (2005)

Spectrophotometric Method for Simultaneous Estimation of Escitalopram Oxalate and Clonazepam in Tablet Dosage Form
por: Kakde, R. B., et al.
Publicado: (2009)

Incidence and predictive factors of non adherence to therapy in young adults attending a psycho social center in Milan: a retrospective observational “Real world” study
por: Vanzetto, S., et al.
Publicado: (2022)

Criminal behaviors and substance abuse in psychiatric patients
por: Benatti, B., et al.
Publicado: (2023)

Behavioral restriction, lorazepam, and escitalopram uniquely influence the expression of naturalistic stereotypy in deer mice: perspectives on anxiety- and compulsive-like behavior
por: Burke, Johann T., et al.
Publicado: (2022)

Lithium overdosage and related tests
por: Pigatto, Paolo D., et al.
Publicado: (2016)

Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter
por: Vanzetto, S., et al.
Publicado: (2021)

Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
por: Buoli, Massimiliano, et al.
Publicado: (2012)

Defining and Understanding Treatment Resistance in Obsessive-Compulsive Disorder
por: Dell’Osso, B.
Publicado: (2023)

Treatment Options for Problematic Internet Use
por: Dell’Osso, B.
Publicado: (2023)

Polypharmacy as maintenance treatment in bipolar illness: A systematic review
por: Amerio, Andrea, et al.
Publicado: (2021)

The impact of lifestyle on adherence to treatment in a sample of patients with Major Depression
por: Conti, D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4006jg698puf012rr9hor1872